Risk of Macrophage Activation Syndrome in Patients with Adult-Onset Still’s Disease Treated with IL-1 and IL-6 Inhibitors: A Meta-analysis and Single-Center Experience-Reference-Cited by-同舟云学术

Risk of Macrophage Activation Syndrome in Patients with Adult-Onset Still’s Disease Treated with IL-1 and IL-6 Inhibitors: A Meta-analysis and Single-Center Experience

Published:2023-10-04 Issue:6 Volume:10 Page:1623-1636
ISSN:2198-6576
Container-title:Rheumatology and Therapy
language:en
Short-container-title:Rheumatol Ther

Author:

Adachi Soichiro,Takase-Minegishi Kaoru^ORCID,Maeda Ayaka,Nagai Hideto,Horita Nobuyuki,Yoshimi Ryusuke,Kirino Yohei,Nakajima Hideaki

Funder

Japan Society for the Promotion of Science

Publisher

Springer Science and Business Media LLC

Subject

Immunology and Allergy,Rheumatology

Link

https://link.springer.com/content/pdf/10.1007/s40744-023-00600-x.pdf

Reference40 articles.

1. Mimura T, Kondo Y, Ohta A, Iwamoto M, Ota A, Okamoto N, et al. Evidence-based clinical practice guideline for adult Still’s disease. Mod Rheumatol. 2018;28(5):736–57.

2. Mitrovic S, Fautrel B. Clinical phenotypes of adult-onset Still’s disease: New insights from pathophysiology and literature findings. J Clin Med. 2021;10(12):2633.

3. Feist E, Mitrovic S, Fautrel B. Mechanisms, biomarkers and targets for adult-onset Still’s disease. Nat Rev Rheumatol. 2018;14(10):603–18.

4. Castañeda S, Blanco R, González-Gay MA. Adult-onset Still’s disease: Advances in the treatment. Best Pract Res Clin Rheumatol. 2016;30(2):222–38.

5. Zhou S, Qiao J, Bai J, Wu Y, Fang H. Biological therapy of traditional therapy-resistant adult-onset Still’s disease: an evidence-based review. Ther Clin Risk Manag. 2018;14:167–71.

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Adult-Onset Still’s Disease (AOSD)—On the Basis of Own Cases;Biomedicines;2024-09-10

2. Successful maintenance therapy with tocilizumab for severe acute liver failure associated with adult-onset still’s disease;Immunological Medicine;2024-08-05

3. Neutrophil activation biomarker pentraxin 3 for diagnosis and monitoring of macrophage activation syndrome occurrence in adult-onset Still's disease;Journal of Autoimmunity;2024-04

4. Interleukin-6 Immunology in Macrophage Activation Syndrome Related to Neuroimmunological Diseases;Internal Medicine;2024